journal
MENU ▼
Read by QxMD icon Read
search

Transplantation Reviews

journal
https://www.readbyqxmd.com/read/27884503/steering-between-scylla-and-charybdis-picking-out-the-optimum-time-of-double-j-stent-removal-following-renal-transplantation
#1
REVIEW
Chrysoula Argyrou, Demetrios Moris, Spiridon Vernadakis
No abstract text is available yet for this article.
November 4, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27884502/the-role-of-arterial-conduits-for-revascularisation-in-adult-orthotopic-liver-transplantation
#2
REVIEW
Nikolaos A Chatzizacharias, Mohamed Aly, Raaj K Praseedom
The successful outcome in orthotopic liver transplantation (OLT) is critically dependent on the uncompromised hepatic graft blood inflow. Arterial conduits represent a good solution in cases where conventional revascularisation is not possible. The purpose of this systematic review is to analyse the published evidence on the use of arterial conduits in adult OLT. After review of the Pubmed and EMBASE databases, 19 relevant studies were identified and analysed. Even though patient survival was comparable, most large studies reported worse 1-, 3- and 5-year graft survival rates compared to grafts with standard arterial revascularisation...
November 4, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27847221/chronic-allograft-injury-mechanisms-and-potential-treatment-targets
#3
REVIEW
Leonardo V Riella, Arjang Djamali, Julio Pascual
Improving long-term graft survival remains one of the critical challenges facing kidney transplantation since a great portion of kidney grafts are lost by 10years after transplantation. Understanding the causes of chronic allograft injury and providing timely therapeutic interventions are essential for improving these outcomes. In this review, we will discuss the recent data that emerged turning down calcineurin inhibitors as the primary cause of long-term graft injury and highlighting the increased importance of non-compliance, antibody-mediated injury, disease recurrence, and BK nephropathy as culprits...
October 11, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27776929/kidney-transplantation-for-hiv-positive-patients
#4
Deirdre Sawinski
HIV+ patients are at increased risk for end-stage renal disease, but HIV infection was once considered a contraindication to renal transplantation. However, contemporary studies from the United States and Europe have now demonstrated that renal transplantation is a safe and effective treatment for end-stage renal disease in HIV patients, with equivalent patient and allograft survival to those uninfected. Broader experience in transplantation in HIV+ patients has identified unique challenges including high rates of acute rejection, delayed graft function, and significant drug-drug interactions...
October 11, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27836384/sensitization-assessment-before-kidney-transplantation
#5
REVIEW
Ben C Reynolds, Kathryn J Tinckam
Kidney transplantation is the treatment of choice for patients with end stage renal disease to optimize survival, freedom from morbidity and quality of life. A fundamental aspect of the pre-transplant assessment is a thorough understanding of their immunological history and prior exposures, so that the immunological risk from a given donor can be estimated, if not quantified, in order to guide interventions to optimize transplant access and success. The methodologies available to complete this assessment have evolved rapidly, with flow cytometric based analyses now standard in many laboratories, availability of comprehensive molecular methods for HLA typing of both donors and recipients, and an increasing recognition of the vital dialogue that must occur between the HLA laboratory and transplant clinicians...
October 8, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27671053/liver-transplantation-in-transthyretin-amyloidosis-characteristics-and-management-related-to-kidney-disease
#6
Ana Rocha, Luísa Lobato
Orthotopic liver transplantation (LT) was implemented as the inaugural disease-modifying therapy for hereditary transthyretin (ATTR) amyloidosis, a systemic amyloidosis mainly affecting the peripheral nervous system and heart. The first approach to pharmacologic therapy was focused on the stabilization of the TTR tetramer; following that new advent LT was assumed as the second step of treatment, for those patients whose neuropathy becomes worse after a course of pharmacologic therapy. The renal disease has been ignored in hereditary ATTR amyloidosis...
September 14, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27665059/drug-drug-interactions-between-immunosuppressants-and-antidiabetic-drugs-in-the-treatment-of-post-transplant-diabetes-mellitus
#7
Thomas Vanhove, Quinten Remijsen, Dirk Kuypers, Pieter Gillard
Post-transplant diabetes mellitus is a frequent complication of solid organ transplantation that generally requires treatment with lifestyle interventions and antidiabetic medication. A number of demonstrated and potential pharmacokinetic drug-drug interactions (DDIs) exist between commonly used immunosuppressants and antidiabetic drugs, which are comprehensively summarized in this review. Cyclosporine (CsA) itself inhibits the cytochrome P450 (CYP) 3A4 enzyme and a variety of drug transporters. As a result, it increases exposure to repaglinide and sitagliptin, will likely increase the exposure to nateglinide, glyburide, saxagliptin, vildagliptin and alogliptin, and could theoretically increase the exposure to gliquidone and several sodium-glucose transporter (SGLT)-2 inhibitors...
September 14, 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27553809/hematopoietic-stem-cells-and-solid-organ-transplantation
#8
REVIEW
Reza Elahimehr, Andrew T Scheinok, Dianne B McKay
Solid organ transplantation provides lifesaving therapy for patients with end stage organ disease. In order for the transplanted organ to survive, the recipient must take a lifelong cocktail of immunosuppressive medications that increase the risk for infections, malignancies and drug toxicities. Data from many animal studies have shown that recipients can be made tolerant of their transplanted organ by infusing stem cells, particularly hematopoietic stem cells, prior to the transplant. The animal data have been translated into humans and now several clinical trials have demonstrated that infusion of hematopoietic stem cells, along with specialized conditioning regimens, can permit solid organ allograft survival without immunosuppressive medications...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27534874/from-chronic-kidney-disease-to-kidney-transplantation-the-impact-of-obesity-and-its-treatment-modalities
#9
REVIEW
Brian Camilleri, Julie M Bridson, Ajay Sharma, Ahmed Halawa
Obesity is associated with worse short-term outcomes after kidney transplantation but the effect on long-term outcomes is unknown. Although some studies have reported worse outcomes for obese recipients when compared to recipients with a BMI in the normal range, obese recipients who receive a transplant have better outcomes than those who remain wait-listed. Whether transplant candidates should be advised to lose weight before or after transplant has been debated and this is mainly due to the gap in the literature linking pre-transplant weight loss with better outcomes post-transplantation...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27531698/biliary-complications-following-living-donor-hepatectomy
#10
REVIEW
Hillary J Braun, Nancy L Ascher, Garrett R Roll, John P Roberts
BACKGROUND: Living donor liver transplantation (LDLT) has become increasingly common in an effort to increase organ availability for the treatment of end-stage liver disease. Donor safety is a primary concern in LDLT. The majority of complications experienced by living donors are infectious or biliary in nature. The purpose of this paper was to review the existing literature on biliary complications in living donors. METHODS: Studies were eligible for inclusion if they were published in English between 2006-present, focused on adult-to-adult LDLT, and were available via PubMed/MEDLINE...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27531697/from-hla-typing-to-anti-hla-antibody-detection-and-beyond-the-road-ahead
#11
REVIEW
Antonietta Picascia, Vincenzo Grimaldi, Claudio Napoli
The complex polymorphism of the HLA genes and the need of a proper identification of anti-HLA antibodies have led to continuously develop novel practical and feasible technologies in the field of organ and tissue transplantation. Technologies to identify HLA molecules have evolved from the serological to the molecular methods and a true innovation in the DNA sequencing has taken place with the development of next generation sequencing. An interesting field to explore is how the information resulting from the HLA-DNA sequencing can be applied in the clinical setting by including the alloimmunization assessment...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27527917/combined-heart-liver-transplantation-indications-outcomes-and-current-experience
#12
REVIEW
Eliza W Beal, Khalid Mumtaz, Don Hayes, Bryan A Whitson, Sylvester M Black
Combined heart-liver transplantation is a rare, life-saving procedure that treats complex and often fatal diseases including familial amyloidosis polyneuropathy and late stage congenital heart disease status-post previous repair. There were 159 combined heart-liver transplantations performed between January 1, 1988 and October 3, 2014 in the United States. A multitude of potential techniques to be used for combined heart and liver transplant including: orthotopic heart transplant (OHT) and orthotopic liver transplant (OLT) on full cardiopulmonary bypass (CPB), OHT with CPB and OLT with venovenous bypass (VVB), OHT with CPB and OLT without VVB, en-bloc technique and sequential transplantation...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27515042/multiorgan-transplantation
#13
REVIEW
Erik Stites, Alexander C Wiseman
Kidney transplantation has proven to be the gold standard therapy for severe chronic kidney disease (CKD) due to multiple etiologies in individuals deemed eligible from a surgical standpoint. While kidney transplantation is traditionally considered in conditions of native kidney disease such as diabetes and immunological or inherited causes of kidney disease, an increasing indication for kidney transplantation is kidney dysfunction in the setting of other severe organ dysfunction that requires transplant, such as severe liver or heart disease...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27496067/safety-adherence-and-efficacy-of-exercise-training-in-solid-organ-transplant-candidates-a-systematic-review
#14
REVIEW
Matthew P Wallen, Tina L Skinner, Toby G Pavey, Adrian Hall, Graeme A Macdonald, Jeff S Coombes
BACKGROUND: Patients awaiting solid-organ transplantation may be encouraged to undertake exercise training to improve pre- and post-transplant outcomes. However, the safety, adherence and efficacy of exercise training in this population remain unclear. METHODS: All randomized, non-randomized and non-controlled trials of exercise training interventions in solid-organ transplant candidates were included. The Cochrane risk of bias tool and a modified Newcastle-Ottawa scale were used to assess procedural quality...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27477938/the-role-of-osmotic-self-inflatable-tissue-expanders-in-intestinal-transplant-candidates
#15
REVIEW
Laurens J Ceulemans, Nathalie P Deferm, Marc Miserez, Francesca Maione, Diethard Monbaliu, Jacques Pirenne
Intestinal transplantation (ITx) is often associated with decreased abdominal domain, rendering abdominal closure difficult. Pre-transplant placement of tissue expanders (TE) can overcome this challenge; however it can be associated with life-threatening complications. This review aimed to comprehensively summarize all available literature on TE in ITx candidates and include the technical details of osmotic, self-inflatable TE -a technique undescribed before. PubMed, EMBASE and CCTR were searched until April 30, 2016...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27395083/clinical-value-of-non-hla-antibodies-in-kidney-transplantation-still-an-enigma
#16
REVIEW
Laura A Michielsen, Arjan D van Zuilen, Merle M Krebber, Marianne C Verhaar, Henny G Otten
HLA antibodies play a major role in the recipient's immune response against the renal allograft and are an established risk factor for antibody-mediated rejection and subsequent impaired graft survival. Evidence originating from HLA-identical donor-recipient pairs indicates that non-HLA antibodies may play a role as well. Numerous non-HLA antibodies have been identified in renal organ transplantation, directed against a heterogeneous subset of both allo- and autoantigens including MHC Class-I-related chain A (MICA) and Angiotensin II type 1 receptor (AT1R)...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27296889/computational-immuno-biology-for-organ-transplantation-and-regenerative-medicine
#17
REVIEW
Gustavo A Vásquez-Montoya, Juan S Danobeitia, Luis A Fernández, Juan P Hernández-Ortiz
Organ transplantation and regenerative medicine are adopted platforms that provide replacement tissues and organs from natural or engineered sources. Acceptance, tolerance and rejection depend greatly on the proper control of the immune response against graft antigens, motivating the development of immunological and genetical therapies that prevent organ failure. They rely on a complete, or partial, understanding of the immune system. Ultimately, they are innovative technologies that ensure permanent graft tolerance and indefinite graft survival through the modulation of the immune system...
October 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27279024/immunosuppression-in-the-elderly-renal-allograft-recipient-a-systematic-review
#18
REVIEW
Nuria Montero, María José Pérez-Sáez, Julio Pascual, Daniel Abramowicz, Klemens Budde, Chris Dudley, Mark Hazzan, Marian Klinger, Umberto Maggiore, Rainer Oberbauer, Julio Pascual, Soren S Sorensen, Ondrej Viklicky
BACKGROUND: The Elderly are the fastest growing part of kidney transplant recipients. The best immunosuppressive strategy is unknown. METHODS: We performed a systematic search of randomized controlled trials and observational studies focused on safety and efficacy of different immunosuppression strategies in elderly kidney recipients. Data extraction and risk of bias evaluation were systematically performed. RESULTS: Ten studies were included: 2 randomized clinical trials and 8 observational...
July 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27158081/ex-vivo-liver-perfusion-for-organ-preservation-recent-advances-in-the-field
#19
REVIEW
A S Barbas, N Goldaracena, M J Dib, M Selzner
Liver transplantation is the optimal treatment for end-stage liver disease but is limited by the severe shortage of donor organs. This shortage has prompted increased utilization of marginal grafts from DCD and extended criteria donors, which poorly tolerate cold storage in comparison to standard criteria grafts. Ex-vivo liver perfusion (EVLP) technology has emerged as a potential alternative to cold storage for organ preservation, but there is no consensus regarding the optimal temperature or conditions for EVLP...
July 2016: Transplantation Reviews
https://www.readbyqxmd.com/read/27132815/management-of-cytomegalovirus-infection-in-solid-organ-transplant-recipients-set-gesitra-seimc-reipi-recommendations
#20
REVIEW
J Torre-Cisneros, J M Aguado, J J Caston, L Almenar, A Alonso, S Cantisán, J Carratalá, C Cervera, E Cordero, M C Fariñas, M Fernández-Ruiz, J Fortún, E Frauca, J Gavaldá, D Hernández, I Herrero, O Len, F Lopez-Medrano, N Manito, M A Marcos, P Martín-Dávila, V Monforte, M Montejo, A Moreno, P Muñoz, D Navarro, P Pérez-Romero, A Rodriguez-Bernot, J Rumbao, R San Juan, J M Vaquero, E Vidal
Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant centers, in 2011 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, new publications have clarified or questioned the aspects covered in the previous document...
July 2016: Transplantation Reviews
journal
journal
29805
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"